MAPS PBC Seeks Approval of MDMA-Assisted Therapy for PTSD
MAPS Public Benefit Corporation is seeking approval of its MDMA (midomafetamine capsules)-assisted therapy for posttraumatic stress disorder.
Source: empr.com
Page 48 - Priority Review News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Priority Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Priority Review Today - Breaking & Trending Today
Mitsubishi Tanabe Pharma Canada's commitment to Canadians living with ALS
“ focused on areas that we believe will have the greatest impact for patients – both within and beyond medicine”
Source: macleans.ca
The First Leap to Receive Approval for a Novel Approach to PTSD Treatment | Husch Blackwell LLP
On December 12, 2023, the Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (“MAPS PBC”) announced it has submitted a new drug application (“NDA”) to the...
Source: jdsupra.com
FDA Grants Priority Review to Tarlatamab for Small Cell Lung Cancer
The FDA has accepted and granted priority review to the biologics license application seeking the approval of tarlatamab for the treatment of patients with advanced small cell lung cancer.
Source: onclive.com
FDA Clears ABK Biomedical's Eye90 Microspheres for Hepatocellular Carcinoma Treatment | Knobbe Martens
ABK Biomedical successfully secured Breakthrough Device Designation from the FDA on December 5, 2023, for its Eye90 microspheres device, which is indicated for the treatment of...
Source: jdsupra.com